TASLY(SH:600535)2015-04-28 16:00Financial Performance - Net profit attributable to shareholders of the listed company rose by 20.68% to CNY 334,321,041.58 year-on-year[6] - Operating revenue grew by 2.08% to CNY 3,074,821,898.50 compared to the same period last year[6] - Basic and diluted earnings per share increased by 21.46% to CNY 0.3198[6] - Total revenue for Q1 2015 was CNY 3,078,212,059.97, a slight increase from CNY 3,016,291,408.38 in the same period last year, representing a growth of approximately 2.06%[41] - Net profit for Q1 2015 reached CNY 357,530,316.86, up from CNY 346,230,340.43 in Q1 2014, reflecting a growth of approximately 3.74%[42] - Total comprehensive income attributable to the parent company was CNY 345,513,327.58, up from CNY 284,463,425.61, representing a growth of 21.5%[47] Cash Flow - The company experienced a significant decline in cash flow from operating activities, with a net cash flow of -CNY 24,592,297.00, a decrease of 109.24% year-on-year[6] - Cash flow from operating activities showed a net outflow of CNY 24,592,297.00, a significant decrease from a net inflow of CNY 266,120,121.98 in the same period last year[50] - Cash inflow from operating activities totaled 870,012,904.55 RMB, down 28% from 1,208,983,116.36 RMB year-over-year[52] - Cash outflow from operating activities increased to 1,629,891,451.86 RMB, up 57.6% from 1,032,759,133.80 RMB in the previous period[52] - The net cash flow from investing activities was -192,080,169.42 RMB, an improvement from -901,724,634.64 RMB in the same period last year[53] - Total cash inflow from financing activities reached 3,197,211,068.37 RMB, significantly higher than 1,089,910,036.20 RMB in the previous period[53] Assets and Liabilities - Total assets increased by 8.51% to CNY 14,020,681,372.85 compared to the end of the previous year[6] - The total liabilities decreased to CNY 6,734,740,416.15, down from CNY 7,564,706,295.39, indicating a decrease of approximately 11%[34] - Current liabilities decreased to CNY 5,936,972,343.84 from CNY 6,766,840,019.37, a reduction of approximately 12.3%[34] - The total liabilities decreased to CNY 2,981,080,242.50 from CNY 4,278,375,987.37, a reduction of approximately 30.19%[39] Shareholder Information - The total number of shareholders reached 30,633[15] - Tianjin Tianshili Holding Group Co., Ltd. holds 488,201,106 shares, accounting for 45.18% of total shares[15] - The net assets attributable to shareholders of the listed company increased by 39.75% due to the private placement[9] - The equity attributable to shareholders of the parent company increased to CNY 6,493,320,500.22 from CNY 4,650,682,507.21, representing a growth of about 39.52%[39] Capital and Investments - The company completed a private placement of 47,633,224 shares at CNY 33.59 per share, raising a total of CNY 1,577,395,994.16 after expenses[8] - The company's capital reserve increased by 1,529,762,770.16 RMB, a growth rate of 625.91% due to a premium from a directed issuance[18] - The company completed a directed issuance of 47,633,224 shares at a price of 33.59 RMB per share, raising significant capital[20] - The company received a total of RMB 25,952.80 million in relocation compensation, with RMB 6,087.65 million still outstanding[24] Operational Efficiency - The weighted average return on net assets decreased by 0.20 percentage points to 6.90%[6] - The company has committed to ensuring compliance with legal regulations and maintaining transparency in related party transactions to enhance operational efficiency and profitability[28] - The company and its major shareholders have continued to strictly fulfill their commitments regarding profit forecasts and compensation agreements[26] - The company has committed to avoiding any competition with its parent company and ensuring independent operations in production, supply, and sales[27] Revenue Breakdown - The pharmaceutical industrial revenue grew by 11.29% year-on-year, while pharmaceutical commercial revenue decreased by 6.08%[7] - The company's revenue from non-operating income increased by 49.64%, reaching 9,964,979.15 RMB[19] - The investment income rose by 45.72%, amounting to 2,625,826.49 RMB, attributed to the disposal of subsidiaries[19] Changes in Assets - The company's current assets totaled CNY 8,875,575,548.87, up from CNY 7,788,405,051.42 at the beginning of the year, indicating an increase of about 14%[33] - Accounts receivable rose to CNY 4,612,770,426.66 from CNY 3,558,680,816.92, reflecting a significant increase of approximately 29.6%[33] - Inventory levels increased to CNY 1,543,005,863.14 from CNY 1,476,640,578.62, marking an increase of about 4.5%[33] - The company reported a total non-current asset value of CNY 5,145,105,823.98, slightly up from CNY 5,132,943,986.90, reflecting a marginal increase of 0.2%[34]